The media is highlighting the Viagra story of the day "insurance reimbursement". In time, I believe most insurance companies will provide guidelines for reimbursing Viagra. Given the dramatic Viagra specification, they are reasonably concerned about future costs and the impact on their bottom line.
The real story that is being missed is the dramatic breakdown of the stigma of impotence by males in the US. Since the availability of Viagra earlier this month, over nine times as many men are going to physicians to discuss their sexual health. This is absolutley amazing and has happened without a major effort from PFE.
Remember, prior to Viagra, only 5% of men with ED would even bother to seek treatment. It is clear the reason was primarily the types of undesirable treatments that were previously available. With Viagra, this is rapidly changing. Men with ED problems are admitting it and actually doing something about the problem..... Unusual for men when it comes to their own health. This fact must be surprising to insurance companies, physicians, PFE and spouses/lovers.
Based on this changing market and the strength of Viagra and Lipitor, I believe PFE is a major buy at any signs of major weakness and a buy right at this minute.
Finally, the use of Viagra in women, the media frenzy, biased analysts' reports, hype by posters, insurance reimbursement are all just noise in the ED market.
The key is specification: New Rxs and refill Rxs. These Rx trends will forecast the future price of PFE. At this point, even the most optimistic Viagra forecasts have been exceeded. However, the next one month and 3 month data will be important indicators for the future to 2011 (the patent expiration date for the big V).
Accordingly, I am raising my own personal target PFE 1998 high (posted in January 1998) from 125 to 150. Since I am DRIPing tomorrow, I hope PFE heads down on Thursday and starts the big 34% climb on Friday.
Remember: Specification, specification, specification
BigKNY3 |
